Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Character Biosciences logo — A patient-driven drug discovery platform for diseases of agi...

Character Biosciences

A patient-driven drug discovery platform for diseases of aging

Founded 2019 United States San Francisco, United States 36 employees Series A Total: $27.00M Biotechnology, Health Care +1

General Information

Company Name Character Biosciences
Founded Year 2019
Location United States San Francisco, United States +3
Founders / Decision Makers
Team member
Employees 36
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when Character Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Character Biosciences

Character Biosciences is a precision medicine platform with the slogan "A patient-driven drug discovery platform for diseases of aging." The company, formerly known as Clover Therapeutics, is focused on unlocking the patterns of age-related diseases in diverse populations. Founded in 2018, their mission is to use human genetics to understand the underlying causes of diseases with the aim of discovering targeted therapies for more effective treatments, particularly for patients lacking treatment options. Character Biosciences partners with patients, providers, payers, and scientists to create deeply-phenotyped patient cohorts and to enable clinical genomic research. Their approach integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify molecular drivers of disease progression and develop innovative targeted medicines. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries and is based in the United States. Their most recent investment was a Series A investment on 2nd September 2022, with Shane Neman being the investor. Overall, Character Biosciences' focus on precision medicine, patient-centric approach, and innovative methodologies for drug discovery position them as a promising player in addressing diseases of aging through targeted therapies.

Taxonomy: precision medicine, drug discovery, patient-driven, genomics, clinical research, therapeutics, aging diseases, molecular drivers, longitudinal data, patient cohorts, privacy, ethics, data security, patient health

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 1 •••• •••• 02 Sep 2022
Series A •••••• 8
Investor Investor Investor Investor Investor Investor
•••• •••• 		17 May 2022
Seed Round •••••• 1
Investor
01 Apr 2020
Pre Seed Round •••••• - 15 Sep 2019

Character Biosciences Alternatives & Competitors

Character Biosciences vs
BCB Medical Ltd
BCB Medical Ltd Finland

We are #hiring! BCB Medical - Bringing Data To Life

Private Equity
77 employees
Health Care
Compare Character Biosciences vs BCB Medical Ltd
Character Biosciences vs
Priovant Therapeutics
Priovant Therapeutics United States

Developing targeted therapies for patients with severe autoimmune disease

139 employees
Character Biosciences vs
Sanius Health
Sanius Health United Kingdom

Sanius Health is a patient-owned company which focuses primarily on patients living with Sickle Cell...

26 employees
Health Care, Mobile
Compare Character Biosciences vs Sanius Health
Also compare with: Character Biosciences vs Aparito - a wholly owned subsidiary of Eli Lilly and Company Aparito - a wholly owned subsidiary of Eli Lilly and Company

FAQ About Character Biosciences

A patient-driven drug discovery platform for diseases of aging
Character Biosciences was founded in 2019.
Character Biosciences is headquartered in San Francisco, United States.
Character Biosciences operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Character Biosciences has approximately 36 employees.
Character Biosciences has completed 4 funding rounds, raising a total of $27.00M. The latest funding stage is Series A.
Top alternatives and competitors to Character Biosciences include BCB Medical Ltd, Priovant Therapeutics, Sanius Health, Aparito - a wholly owned subsidiary of Eli Lilly and Company, Stealth BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Character Biosciences and BCB Medical Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Character Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy